Ek B A, Nahorski S R
Gastroenterology. 1986 Feb;90(2):408-13. doi: 10.1016/0016-5085(86)90940-6.
The specific binding of 125I-(-)pindolol to membranes prepared from rat colon displayed high affinity (Kd = 75 +/- 3 pM) and relatively low capacity (Bmax = 48 +/- 3.8 fmol/mg protein). Furthermore, the binding was reversible and possessed properties expected of a beta-adrenoceptor. Thus, for example, the potency of agonists in displacing 125I-(-)pindolol was, in decreasing order, isoproterenol greater than epinephrine greater than norepinephrine, and the negative isomer of propranolol was two orders of magnitude more potent than the positive isomer. Displacement of specific binding by the beta 1-adrenoceptor antagonist pafenolol and the beta 2-adrenoceptor antagonist ICI 118.551 revealed that the colon preparation possessed a heterogenous beta-adrenoceptor population. Analysis of the inhibition curves using computer-assisted curve fitting suggested that the sites consisted of a small (14%-21%) beta 1-adrenoceptor population and a large (79%-86%) beta 2-adrenoceptor population. The coexistence of beta 1- and beta 2-adrenoceptors is discussed in relation to evidence of a functional linkage of both subtypes with colon motility.
125I-(-)吲哚洛尔与大鼠结肠制备的膜的特异性结合显示出高亲和力(Kd = 75±3 pM)和相对低的容量(Bmax = 48±3.8 fmol/mg蛋白质)。此外,这种结合是可逆的,并且具有β-肾上腺素能受体预期的特性。因此,例如,激动剂取代125I-(-)吲哚洛尔的效力由高到低依次为异丙肾上腺素>肾上腺素>去甲肾上腺素,普萘洛尔的负性异构体比正性异构体的效力强两个数量级。β1-肾上腺素能受体拮抗剂帕非洛尔和β2-肾上腺素能受体拮抗剂ICI 118.551对特异性结合的取代表明,结肠制备物具有异质性的β-肾上腺素能受体群体。使用计算机辅助曲线拟合对抑制曲线进行分析表明,这些位点由少量(14%-21%)的β1-肾上腺素能受体群体和大量(79%-86%)的β2-肾上腺素能受体群体组成。结合β1-和β2-肾上腺素能受体与结肠运动功能联系的证据,对这两种亚型的共存进行了讨论。